Kb Financial Partners, LLC Ionis Pharmaceuticals Inc Transaction History

Kb Financial Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$29.88 - $37.04 $1,015 - $1,259	-34 Closed	0 $0
Q4 2021 Feb 18, 2022	BUY	$25.61 - $35.1 $870 - $1,193	34 New	34 $1,000
Q3 2021 Nov 16, 2021	SELL	$33.54 - $40.55 $135,166 - $163,416	-4,030 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$34.54 - $47.25 $60,928 - $83,349	1,764 Added 77.85%	4,030 $161,000
Q1 2021 Jun 08, 2021	BUY	$42.51 - $63.78 $96,327 - $144,525	2,266 New	2,266 $102,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Kb Financial Partners, LLC with notifications on news.